Versalife

Versalife
Versalife
artist
artist.tools
Playlist Risks
Listeners
Est. Royalties

Charts

Tracks

Playlists

Press Mentions

Google Rankings

Overview

Monthly Listeners

Monthly Listeners1,684-4.0%7dListeners from Playlists690+4.5%7dChangeN/A—

Series

  • Monthly Listeners
  • Listeners from Playlists
  • Change

Discography

Their catalog as it appears on their public Spotify artist profile
7
Albums
13
EPs
12
Singles
Total Streams

Genres

Spotify has not assigned genres to this artist yet

View Versalife's most-streamed songs

Top Audiences

Top listener locations as determined by Spotify

Top Listener Locations

GBLondon, GB69
DEBerlin, DE57
NLAmsterdam, NL33
AUMelbourne, AU25
USLos Angeles, US21

Playlist Summary

Overview of this artist's relationship with playlists
1,092
Playlist adds
0
High-risk playlist adds
160,002
Playlist follower reach (sum)
690+
Listeners from playlists
Estimated
41.0%
Of listeners from playlists
Estimated

Playlist Movement

Recent playlist add/remove events for this artist
Event
Playlist
Botted?
Position
Track
Happened at

Biography & Metadata

Electro leaning project by Conforce aka Boris Bunnik. Bookings: [email protected] The VersaLife corp is a multinational company active since the 1970s. It specializes in pharmaceuticals, bioengineering and nanotechnology. The VersaLife corp is a multinational company active since the 1970s. It specializes in pharmaceuticals, bioengineering and nanotechnology. VersaLife is a subsidiary of the firm Page Industries, whose owner is Bob Page. Its headquarters is located in Hong Kong, and has other major facilities such as in Roccasecca Beach, off the coast of San Francisco, USA. The company was founded in 1976 as Versatile Life Solutions. In 1993, one of VersaLife's subsidiaries, White Helix Labs, performed a series of experiments on newborn babies, likely as part of an early attempt to develop augmentation technology. Adam Jensen was the only survivor of this series of experiments, thought lost when his birth parents burnt down the labs. The years prior to 2000 were described as VersaLife's "golden age", until it went into a sharp decline. Despite this, however, in 2008 it was one of several major biotech companies to participate in biotech research at the controversial Omega Ranch. VersaLife was eventually delisted from the NYSE as it continued to fall in value. This all changed in 2016 when the failing pharmaceutical giant was purchased by the holding company, Page Industries. VersaLife did not start making a profit until it had been acquired by the larger conglomerate.

Updated Nov 14, 2026, 2:58 AM
First discovered Sep 2, 2026, 9:35 PM